Cigna Group (CGN) Stock Overview
Provides insurance and related products and services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CGN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Cigna Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$232.35 |
| 52 Week High | US$268.40 |
| 52 Week Low | US$210.05 |
| Beta | 0.23 |
| 1 Month Change | -5.91% |
| 3 Month Change | -0.32% |
| 1 Year Change | n/a |
| 3 Year Change | -8.31% |
| 5 Year Change | 13.90% |
| Change since IPO | 184.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| CGN | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.7% | -1.7% | -0.08% |
| 1Y | n/a | 5.3% | -2.6% |
Return vs Industry: Insufficient data to determine how CGN performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how CGN performed against the German Market.
Price Volatility
| CGN volatility | |
|---|---|
| CGN Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in DE Market | 14.2% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: CGN has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: CGN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1792 | 66,685 | David Cordani | www.thecignagroup.com |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
The Cigna Group Fundamentals Summary
| CGN fundamental statistics | |
|---|---|
| Market cap | €60.57b |
| Earnings (TTM) | €5.19b |
| Revenue (TTM) | €239.69b |
Is CGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGN income statement (TTM) | |
|---|---|
| Revenue | US$274.90b |
| Cost of Revenue | US$249.34b |
| Gross Profit | US$25.56b |
| Other Expenses | US$19.60b |
| Earnings | US$5.96b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 30, 2026
| Earnings per share (EPS) | 22.59 |
| Gross Margin | 9.30% |
| Net Profit Margin | 2.17% |
| Debt/Equity Ratio | 74.9% |
How did CGN perform over the long term?
See historical performance and comparisonDividends
Does CGN pay a reliable dividends?
See CGN dividend history and benchmarks| Cigna Group dividend dates | |
|---|---|
| Ex Dividend Date | Mar 05 2026 |
| Dividend Pay Date | Mar 19 2026 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 0 days |
Does CGN pay a reliable dividends?
See CGN dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/18 05:40 |
| End of Day Share Price | 2026/03/18 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Cigna Group is covered by 39 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |